Recently, the German medical technology company Xenios acquired the CE mark on the i-cor synchronous cardiac assist system sold in Europe. The i-cor system is the world's first heartbeat synchronous cardiac assist system for cardiogenic shock and high-risk intervention. A miniaturized pump to provide physiological heartbeat assistance. The system can assist the weak heart to beat by using synchronized pulses, and combined with myocardial protection, the sync pulse can cover the entire weak heart of the patient. Xenios says the new system improves coronary blood flow in the patient's heart compared to traditional methods and limits cardiac afterload; company executive director Georg Matheis said the i-cor synchronous cardiac assist system was approved by European regulators It will bring a new era to the development of percutaneous cardiac assistance; we will provide artificial heartbeat for each heart with weakened heartbeat, which was not previously available. Today's synchronized cardiac assist system, unlike the percutaneous continuous flow system, the i-cor synchronous cardiac assist system will be the world's first synchronous mechanical circulation support system for the debilitated heart of the patient; the i-cor system can not only be Patients who suffer from cardiogenic shock provide new treatments that can also help patients with high-risk interventions in the cardiac catheterization room; synchronized cardiac assist systems that cover physiological pulse waves or superimpose patient-attenuated beats compared to standard therapies It is also a minimally invasive treatment. Currently, this system can utilize a physiological therapy required for endothelial function to ensure adequate tissue perfusion in the organ; the oxygenation capacity of this new i-cor system can be reduced by reducing blood flow compared to standard treatments. And the size of the cannula to reduce trauma. Xenios currently has two product brands, the novalung and i-cor systems, which can run on a single Xenios platform, Novalung offers a full range of extrapulmonary support, and the i-cor system focuses on heart treatment. Ningbo Staneex Imp. & Exp. Co., Ltd. , https://www.staneex.com